Clarus Ventures, LLC - VBI VACCINES INC ownership

Quarter-by-quarter ownership
Clarus Ventures, LLC ownership history of VBI VACCINES INC
ValueSharesWeighting
Q3 2018$6,512,000
-12.0%
2,691,0420.0%1.53%
-41.8%
Q2 2018$7,400,000
-21.4%
2,691,0420.0%2.63%
-72.7%
Q1 2018$9,419,000
-18.0%
2,691,0420.0%9.63%
-15.8%
Q4 2017$11,491,000
+10.9%
2,691,0420.0%11.44%
+35.7%
Q3 2017$10,360,000
-11.5%
2,691,0420.0%8.43%
-21.6%
Q2 2017$11,706,000
-20.8%
2,691,0420.0%10.76%
-2.1%
Q1 2017$14,774,000
+77.1%
2,691,0420.0%11.00%
+100.1%
Q4 2016$8,342,000
-9.6%
2,691,0420.0%5.50%
-3.1%
Q3 2016$9,230,000
-13.2%
2,691,0420.0%5.67%
-39.0%
Q2 2016$10,630,0002,691,0429.30%
Other shareholders
VBI VACCINES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 55,042,465$171,182,0002.49%
GENERAL AMERICAN INVESTORS CO INC 1,877,497$5,839,0000.50%
HighVista Strategies LLC 41,271$129,0000.08%
ArchPoint Investors 65,000$202,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 136,714$425,0000.06%
FNY Investment Advisers, LLC 24,683$76,0000.04%
GRIMES & COMPANY, INC. 257,960$802,0000.04%
Cambridge Investment Research Advisors, Inc. 2,065,953$6,425,0000.03%
Ergoteles LLC 171,127$532,0000.02%
J.W. COLE ADVISORS, INC. 71,100$221,0000.02%
View complete list of VBI VACCINES INC shareholders